Yongzhong Yao

2PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 31, 2022
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer.

Wei Wang, Tingting Zhu, Hao Chen

|Nov 17, 2022
Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study.

Zheying Liu, Yinan Guan, Yongzhong Yao

Pageof 1

Frequent Collaborators